Indrayani Biotech Peer Comparison

BSE: 526445

₹9.36

₹-0.42 (-4.29%)

As on 18-Sep-2026IST

Market cap

₹43 Cr

Revenue (TTM)

₹173 Cr

P/E Ratio

19.7

P/B Ratio

0.6

Div. Yield

0 %

Edit

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Market cap (₹ Cr)	43	10,715	303	222	59
Revenue (₹ Cr)	173	23,506	82	434	67
Net Profit (₹ Cr)	2.28	553.62	10.62	17.44	-7.30
Net Margin (%)	1.27	2.35	12.59	3.90	0.51
RoE (%)	2.31	10.18	9.30	6.80	-47.21
Price to Earnings	19.73	19.35	28.47	12.73	--
Price-To-Book	0.58	1.72	2.43	0.85	4.38

Income Statement (₹ Cr)

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Operating Revenue	172.85	23,506.20	82.15	433.83	67.24
Total Income	178.70	23,565.09	84.39	446.74	69.21
Total Expenditure	159.58	21,906.92	64.51	403.95	63.58
EBITDA	13.27	1,599.28	17.64	29.89	3.67
Depreciation	7.93	202.34	4.36	10.72	3.37
EBIT	5.35	1,396.94	13.29	19.17	0.30
Interest	10.76	676.51	0.38	13.08	2.04
Other Income	5.85	58.89	2.25	12.91	1.96
Exceptional Items	0.00	-58.78	-0.60	0.00	0.00
Profit before Tax	0.44	720.54	14.56	18.99	0.22
Provision for Tax	-1.83	166.92	3.93	1.55	-0.13
Profit after Tax	2.28	553.62	10.62	17.44	0.35

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Shareholder's Funds	72.89	6,159.69	122.45	257.94	2.31
Minority Interest	-0.56	0.00	0.00	0.00	0.00
Non-Current Liabilities	58.36	990.55	2.84	58.41	8.14
Current Liabilities	92.98	18,007.82	9.40	236.55	58.01
Total Liabilities	267.94	22,164.37	127.18	526.89	67.56

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Non-Current Assets	89.67	2,057.25	65.46	277.80	36.25
Current Assets	158.72	22,209.08	59.07	249.09	29.17
Total Assets	267.94	22,164.37	127.18	526.89	67.56
Total Debt*	137.07	3,701.10	6.35	139.02	27.63
Net Current Assets	65.74	4,201.26	49.67	12.55	-28.84
Contingent Liabilities	--	179.24	2.63	15.96	4.49

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Cash From Operating Activities	-6.74	419.07	11.60	7.70	1.06
Cash Flow from Investing Activities	24.74	-67.87	-11.76	-6.56	0.20
Cash from Financing Activities	-18.30	-32.12	1.84	-2.92	-1.43
Net Cash Inflow / Outflow	-0.29	319.08	1.67	-1.78	-0.17

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
ROCE (%)	3.19	18.50	9.72	10.22	-11.00
ROE (%)	2.31	10.18	9.30	6.80	-47.21
ROA (%)	0.87	2.34	7.98	3.27	0.52
EBIT Margin (%)	3.09	5.94	16.17	4.42	0.44
Net Margin (%)	1.27	2.35	12.59	3.90	0.51
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Revenue Growth (%)	32.73	5.14	14.86	-2.88	13.95
EBIT Growth (%)	263.11	-0.26	51.89	-4.16	-44.78
Net Profit Growth (%)	137.29	-8.91	39.89	-43.90	202.91
EPS Growth (%)	125.11	-1.20	45.81	-15.97	-158.86
Book Value Growth (%)	9.39	30.56	3.36	12.75	-45.64

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Price / Earnings	24.87	17.84	27.32	12.73	-20.31
Price / Book Value	0.58	1.72	2.43	0.85	4.38
Dividend Yield (%)	0.00	1.37	0.39	0.00	0.00
EV/EBITDA	13.52	9.57	16.17	12.29	23.38
Market Cap (₹ Cr)	64.93	20,830.83	141.26	205.41	60.84

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Debt to Equity	0.79	0.11	0.02	0.13	2.00
Short term debt to equity ratio	0.97	0.60	0.03	0.41	1.76
Current Ratio	1.71	1.23	6.28	1.05	0.50
Quick Ratio	1.30	1.15	4.84	0.60	0.36
Interest Coverage	1.04	2.07	39.41	2.45	1.11

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Debtors to sales (%)	33.89	27.54	26.98	14.56	18.22
Asset Turnover	0.66	0.99	0.62	0.81	0.99
Receivable days	137.64	76.75	91.99	37.44	101.50
Inventory Days	117.29	19.66	67.73	76.25	82.01
Payable days	134.44	237.22	166.81	124.30	185.76
Cash Conversion Cycle	120.49	-140.81	-7.10	-10.61	-2.26

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.